Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announces that the first patient has been dosed in a global multicenter clinical ...

The firm is also considering a US regulatory submission of its QiAcuityDx system along with a companion diagnostic test.

The biotech sector remains one of the most dynamic areas of the market, driven by clinical breakthroughs, regulatory ...

The following is a summary of “Mixed Autoimmune Hemolytic Anemia: A Systematic Review of Epidemiology, Clinical Characteristics, Therapies, and Outcomes,” published in the May 2025 issue of American ...

Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 Supporting Differentiated Profile in Sickle Cell Disease (SCD) at European Hematology Association (EHA) 2025 ...

Disc Medicine announces positive updates on bitopertin, DISC-0974, and DISC-3405, with plans for upcoming clinical trials and data presentations.

As a paradigm-shifting drug discovery approach, RIPTACs are attracting more and more attention from both academic and industrial settings. Recently, Halda Therapeutics, founded by Crews and co-workers ...

Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR 2025 Congress ...

This study investigates the multiple intelligence profiles of prospective physical education teachers and examines how these profiles vary by gender, high school type, and sport participation. A total ...

In his 11 years as mayor of Newark, the city has seen a tremendous growth spurt - the city skyline is etched with new businesses and new partnerships have brought more jobs.